# Phase II Study of Systemic Screening in Pathologic Node Positive Breast Cancer

> **NCT06833502** · PHASE2 · RECRUITING · sponsor: **H. Lee Moffitt Cancer Center and Research Institute** · enrollment: 120 (estimated)

## Conditions studied

- Breast Cancer
- Node-positive Breast Cancer

## Interventions

- **OTHER:** CT Scan

## Key facts

- **NCT ID:** NCT06833502
- **Lead sponsor:** H. Lee Moffitt Cancer Center and Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-24
- **Primary completion:** 2026-10
- **Final completion:** 2026-10
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-04-01

## Collaborators

- Florida Breast Cancer Foundation

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06833502

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06833502, "Phase II Study of Systemic Screening in Pathologic Node Positive Breast Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06833502. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*